Compounds > ad 5075
Page last updated: 2024-09-03

ad 5075 and Insulin Resistance

ad 5075 has been researched along with Insulin Resistance in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, T; Ikeda, H; Meguro, K; Mizuno, K; Momose, Y; Sohda, T1
Bailey, P; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Hayes, NS; Leibowitz, MD; Saperstein, R; Smith, RG1
Adams, AD; Berger, JP; Biswas, C; Doebber, TW; Elbrecht, A; Johnson, BA; Kelly, LJ; Macnaul, KL; Moller, DE; Mosley, R; Parikh, M; Petro, AE; Richards, K; Sharma, N; Surwit, RS; Tanen, MR; Thompson, GM; Ventre, J; Zhang, BB; Zhou, G1
Berger, J; Biswas, C; Doebber, TW; Hayes, N; Ventre, J; Wu, M1
Berger, J; Doebber, T; Li, Z; McCrary, C; Moller, DE; Ryder, JW; Ventre, J; Woods, J; Wu, M; Zhang, B; Zierath, JR1

Other Studies

5 other study(ies) available for ad 5075 and Insulin Resistance

ArticleYear
Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Journal of medicinal chemistry, 1992, Jul-10, Volume: 35, Issue:14

    Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Mice; Pioglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones

1992
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
    Endocrinology, 1996, Volume: 137, Issue:10

    Topics: Animals; Blood Glucose; COS Cells; Cricetinae; Diabetes Mellitus; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; Mice; Molecular Conformation; Peptide Hydrolases; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Triglycerides

1996
Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
    Molecular endocrinology (Baltimore, Md.), 2003, Volume: 17, Issue:4

    Topics: Adipocytes; Adipose Tissue; Animals; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; Hyperglycemia; Indoles; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Sulfides; Transcription Factors; Weight Gain

2003
An antidiabetic thiazolidinedione potentiates insulin stimulation of glycogen synthase in rat adipose tissues.
    Endocrinology, 1996, Volume: 137, Issue:5

    Topics: Adipose Tissue; Animals; Catecholamines; Drug Synergism; Glucose; Glycogen Synthase; Hypoglycemic Agents; Insulin; Insulin Resistance; Kinetics; Male; Rats; Rats, Wistar; Thiazoles; Thiazolidinediones

1996
Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Endocrinology, 1998, Volume: 139, Issue:12

    Topics: Animals; Deoxyglucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Resistance; Male; Mice; Muscle, Skeletal; Myocardium; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors

1998